Suzhou Metra Medical Technology Co., Ltd. was established in February 2021 and is headquartered in the beautiful Taihu Lake Suzhou High-tech Zone Science and Technology City. The company is committed to the R&D and production of high-end implanted interventional medical devices in the field of peripheral vascular and tumor intervention. In the interventional embolization product line, we have the most comprehensive embolization product line development plan in China.

Our company now has 2 ten thousand grade clean production facilities and supporting R&D laboratories, office areas and other facilities. Suzhou Metra has established a sound and in-depth cooperation foundation with many overseas R&D institutions, Peking University and many large domestic clinical centers. Gradually, a unique and powerful high-end implant intervention medical device R&D platform will be formed. Relying on the company's R&D platform, we are systematically and systematically developing more than 20 high-end innovative implant interventional medical devices.

The controlling investor of Suzhou Metra Medical Technology Co., Ltd. is Shanghai Metra Medical Devices Co., Ltd., which has been deeply involved in the peripheral vascular and tumor interventional consumables market. More than 400 distributors across the country have laid a solid foundation for the marketing of our company's products. The founder of the company, Mr. Liu Wenjing, with more than 20 years of profound interventional market experience combined with the company's outstanding international vision, will bring clinicians and patients with internationally leading clinical treatment solutions.